The Recall Desk
ModerateFDA (Devices)·Z-1714-2020·Announced 2020-04-22

Greiner Bio-One Recalls VACUETTE Coagulation Tubes Due to Anticoagulant Inconsistency

Greiner Bio-One is recalling VACUETTE 2mL 9NC Coagulation Tubes because the sodium citrate anticoagulant levels were inconsistent. The recall affects 1,000,800 units distributed nationwide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II. The hazard involves inconsistent anticoagulant levels, which is a quality defect that could affect test results, but no injuries, illnesses, or hospitalizations are reported in the source text.

Plain-English summary

Greiner Bio-One North America, Inc. is recalling VACUETTE 2mL 9NC Coagulation Tubes (Item no. 454322, Lot no. B1908355) because the product was found to have inconsistent amounts of sodium citrate. The source text notes the tubes were shown to have inconsistent amounts of the 2.3% sodium citrate, although the product description lists the concentration as 3.2%.

Approximately 1,000,800 units were distributed nationwide in the United States, including in New Jersey, Indiana, Tennessee, Michigan, North Carolina, Washington, Kansas, California, Louisiana, Illinois, Maryland, New York, Ohio, Texas, Georgia, Kentucky, Pennsylvania, Colorado, Massachusetts, Puerto Rico, Florida, Arkansas, Oklahoma, and Nebraska.

The recall is classified as Class II by the FDA. No specific instructions for consumers or healthcare providers are provided in the source text beyond the identification of the affected lot and distribution scope.

The recalled product

Product
VACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3.2%. Item no. 454322. Lot no. B1908355.
Affected units
1,000,800

Distribution

Distributed nationwide across the United States.

The notice also names 24 states specifically: